Physiologic and plasma hormone correlates of survival in endotoxic dogs

Effects of opiate antagonists

M. J. Murray, K. P. Offord, T. L. Yaksh

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Two groups of awake dogs were given an iv bolus of endotoxin (3.0 mg/kg from Salmonella typhimurium); one group (n = 9) was pretreated with either naloxone (2.0 mg/kg iv bolus with 1.7 mg/kg·h; n = 6) or naltrexone (2.0 mg/kg iv bolus with repeat bolus of 1.0 mg/kg at 1, 3 and 5 h; n = 3) and the second group (n = 10) received no opiate antagonist. All of nine dogs that were pretreated with an antagonist survived for 24 h, compared to only five of ten dogs that were not pretreated. Survival correlated with improved BP (mean of 91 vs. 61 mm Hg) and cardiac output (3.9 vs. 2.45 L/min) measured during the first 3 h after the infliction of shock. However, both antagonist-treated and nonantagonist-treated survivors had BP and cardiac output which were statistically lower than their baseline values or saline-treated controls at comparable times. Nonsurvivors had significantly higher levels of norepinephrine (peak level: 1149 ng/ml) and epinephrine (peak level: 31.29 ng/ml) than survivors. Opiate antagonists thus appeared to increase survival in a subgroup of dogs that might not otherwise have survived if they had not been so treated; this survival was associated with improved hemodynamics, but not with increased adrenergic activity.

Original languageEnglish (US)
Pages (from-to)39-47
Number of pages9
JournalCritical Care Medicine
Volume17
Issue number1
StatePublished - 1989

Fingerprint

Opiate Alkaloids
Hormones
Dogs
Cardiac Output
Naltrexone
Salmonella typhimurium
Naloxone
Endotoxins
Adrenergic Agents
Epinephrine
Shock
Norepinephrine
Hemodynamics

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Physiologic and plasma hormone correlates of survival in endotoxic dogs : Effects of opiate antagonists. / Murray, M. J.; Offord, K. P.; Yaksh, T. L.

In: Critical Care Medicine, Vol. 17, No. 1, 1989, p. 39-47.

Research output: Contribution to journalArticle

Murray, M. J. ; Offord, K. P. ; Yaksh, T. L. / Physiologic and plasma hormone correlates of survival in endotoxic dogs : Effects of opiate antagonists. In: Critical Care Medicine. 1989 ; Vol. 17, No. 1. pp. 39-47.
@article{b2c89a32b8a64a7ea2e8e59a41b91fbc,
title = "Physiologic and plasma hormone correlates of survival in endotoxic dogs: Effects of opiate antagonists",
abstract = "Two groups of awake dogs were given an iv bolus of endotoxin (3.0 mg/kg from Salmonella typhimurium); one group (n = 9) was pretreated with either naloxone (2.0 mg/kg iv bolus with 1.7 mg/kg·h; n = 6) or naltrexone (2.0 mg/kg iv bolus with repeat bolus of 1.0 mg/kg at 1, 3 and 5 h; n = 3) and the second group (n = 10) received no opiate antagonist. All of nine dogs that were pretreated with an antagonist survived for 24 h, compared to only five of ten dogs that were not pretreated. Survival correlated with improved BP (mean of 91 vs. 61 mm Hg) and cardiac output (3.9 vs. 2.45 L/min) measured during the first 3 h after the infliction of shock. However, both antagonist-treated and nonantagonist-treated survivors had BP and cardiac output which were statistically lower than their baseline values or saline-treated controls at comparable times. Nonsurvivors had significantly higher levels of norepinephrine (peak level: 1149 ng/ml) and epinephrine (peak level: 31.29 ng/ml) than survivors. Opiate antagonists thus appeared to increase survival in a subgroup of dogs that might not otherwise have survived if they had not been so treated; this survival was associated with improved hemodynamics, but not with increased adrenergic activity.",
author = "Murray, {M. J.} and Offord, {K. P.} and Yaksh, {T. L.}",
year = "1989",
language = "English (US)",
volume = "17",
pages = "39--47",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Physiologic and plasma hormone correlates of survival in endotoxic dogs

T2 - Effects of opiate antagonists

AU - Murray, M. J.

AU - Offord, K. P.

AU - Yaksh, T. L.

PY - 1989

Y1 - 1989

N2 - Two groups of awake dogs were given an iv bolus of endotoxin (3.0 mg/kg from Salmonella typhimurium); one group (n = 9) was pretreated with either naloxone (2.0 mg/kg iv bolus with 1.7 mg/kg·h; n = 6) or naltrexone (2.0 mg/kg iv bolus with repeat bolus of 1.0 mg/kg at 1, 3 and 5 h; n = 3) and the second group (n = 10) received no opiate antagonist. All of nine dogs that were pretreated with an antagonist survived for 24 h, compared to only five of ten dogs that were not pretreated. Survival correlated with improved BP (mean of 91 vs. 61 mm Hg) and cardiac output (3.9 vs. 2.45 L/min) measured during the first 3 h after the infliction of shock. However, both antagonist-treated and nonantagonist-treated survivors had BP and cardiac output which were statistically lower than their baseline values or saline-treated controls at comparable times. Nonsurvivors had significantly higher levels of norepinephrine (peak level: 1149 ng/ml) and epinephrine (peak level: 31.29 ng/ml) than survivors. Opiate antagonists thus appeared to increase survival in a subgroup of dogs that might not otherwise have survived if they had not been so treated; this survival was associated with improved hemodynamics, but not with increased adrenergic activity.

AB - Two groups of awake dogs were given an iv bolus of endotoxin (3.0 mg/kg from Salmonella typhimurium); one group (n = 9) was pretreated with either naloxone (2.0 mg/kg iv bolus with 1.7 mg/kg·h; n = 6) or naltrexone (2.0 mg/kg iv bolus with repeat bolus of 1.0 mg/kg at 1, 3 and 5 h; n = 3) and the second group (n = 10) received no opiate antagonist. All of nine dogs that were pretreated with an antagonist survived for 24 h, compared to only five of ten dogs that were not pretreated. Survival correlated with improved BP (mean of 91 vs. 61 mm Hg) and cardiac output (3.9 vs. 2.45 L/min) measured during the first 3 h after the infliction of shock. However, both antagonist-treated and nonantagonist-treated survivors had BP and cardiac output which were statistically lower than their baseline values or saline-treated controls at comparable times. Nonsurvivors had significantly higher levels of norepinephrine (peak level: 1149 ng/ml) and epinephrine (peak level: 31.29 ng/ml) than survivors. Opiate antagonists thus appeared to increase survival in a subgroup of dogs that might not otherwise have survived if they had not been so treated; this survival was associated with improved hemodynamics, but not with increased adrenergic activity.

UR - http://www.scopus.com/inward/record.url?scp=0024585790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024585790&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 39

EP - 47

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 1

ER -